尾部中骨粒瘤的非手术治疗方法
Christos Dorlis1, Nicholas Goody1, Kelly Blacklock1
1From the University of Edinburgh, Edinburgh, Scotland.
Journal of the American Animal Hospital Association
|February 26, 2025
概括
由于大肠杆菌引起的狗的不可切除的尾部中小粒瘤,已成功用长期抗生素治疗. 这一案例突出了医疗管理作为一个可行的选择,当手术切除这种罕见的质量是不可行的.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 比较病理学比较病理学
- 狗医疗 狗医疗 狗医疗
背景情况:
- 尾部中质量在狗中很罕见,通常是由于草种子等外来物体迁移而产生的.
- 手术干预通常是这些群体的首选治疗方法.
研究的目的:
- 报告一例成功的长期医疗治疗狗的不可切除尾部中小粒瘤的病例.
- 强调医疗治疗的潜力,当手术切除是不可行的.
主要方法:
- 一只3岁的斯普林格西班牙犬患有发烧症,嗜睡和咳,通过计算机断层扫描 (CT) 诊断出尾部中质.
- 质量被认为在中枢椎切除过程中是不可切除的. 活检显示了一种慢性颗粒瘤与大肠杆菌隔离.
- 这只狗接受了长期抗生素治疗,CT扫描监测了六个月的质量分辨率.
主要成果:
- 在六个月的抗生素治疗内,尾部中小粒瘤完全消失.
- 计算机断层扫描证实治疗期后没有质量.
结论:
- 长期的抗生素治疗可以有效地治疗狗的不可切除的中小粒瘤,特别是当它们是由细菌感染引起的,如大肠杆菌.
- 这一案例表明,当手术不是可行的选择时,医疗管理可以在罕见的尾巴中质群体中取得成功的结果.
相关概念视频
Mitral Regurgitation III: Medical Management
666
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
666
Mitral Stenosis III: Medical Management
509
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
509
Aortic Regurgitation III: Medical Management
581
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
581
Myocarditis III: Medical Management
342
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
342
Pericarditis III: Medical Management
583
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
583
Aneurysm III: Interprofessional Care
477
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
477


